Latest Breaking News On - Jumet - Page 9 : comparemela.com

(1) Regulatory News: TheraVet (ISIN: BE0974387194 ticker: ALVET), a biotechnology company specialising in osteoarticular treatments for animals, today announces a new use of BIOCERA-VET in a multidisciplinary approach to the treatment of osteosarcoma in dogs. In addition to its ongoing clinical trial in appendicular osteosarcoma as a palliative alternative to limb amputation in dogs, TheraVet is currently evaluating the use of BIOCERA-VET as part of a comprehensive, multidisciplinary and curative approach to the treatment of osteosarcoma in dogs. This innovative treatment consists of a combination of tumour removal, reinforcement of the affected bone by cementoplasty and treatment of the cancer by immunochemical therapy, thus avoiding amputation.

Bruxelles capitaleWaals gewestArthur rouillDavid sayagLouis tilquin olivier bricaudOlivier gauthierAmbre delvalNational veterinary school of toulouseNational veterinary school oniris nantesFinancial communicationsRegulatory newsNational veterinary schoolVet david sayagSmall animal surgeryVeterinary dentistryNational veterinary school oniris